Spring direct naar de hoofdnavigatie of de inhoud

Jennifer Ebner von Eschenbach

Patent attorney

‘Investing that little extra time and effort in IP at the right moment makes your technology go further.’
Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

  • Chemistry
  • Life Sciences
  • European Patent Attorney
  • Senior Associate

Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

Continue reading

Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients.

Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

Working experience

  • Patent Attorney, V.O. (2008-present)
  • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
  • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)

Education

  • PhD in Chemistry, University of Melbourne (1988)
  • MSc in Chemistry, University of Melbourne (1984, with honours)

Publications

  • •Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
  • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
  • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
  • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988

Languages

  • German
  • English

Also see these experts

Peter de Lange

Peter de Lange

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
Frits Schut

Frits Schut

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner
More experts

News

The best-known medicine in the world: Aspirin

At the end of the 19th century, a young researcher from Bayer made one the most significant discoveries ever – the painkiller Aspirin. It was valuable for his employer, and also for his father who suffered from rheumatism. It led to a worldwide success!Continue reading

Potentially new opportunities for patents in the United States

In the USA, one of the requirements against which the conclusions of a patent application can be tested is whether it contains a matter that is eligible for patenting.Continue reading

New on Kluwer Patent Blog: Eli Lilly and Company vs. Fresenius Kabi Nederland B.V., Netherlands

By Bart van Wezenbeek. The scope of a patent is to be interpreted according to Art. 69 EPC and the Protocol. If the literal text is limiting, the question is how the skilled person would understand this limitation.Continue reading

Events

European Patent Seminar

Hotel Excelsior München, Schützenstraße, Munich, Germany

Know the latest ins-and-outs concerning examination, opposition and appeal proceedings before the EPO. Be updated on the unitary patent and the unified patent court. Continue reading

Improve your practical knowledge at the IP Academy – Basic

Winthontlaan 6, 3526 KV Utrecht, Utrecht, Netherlands

Follow the annual course on patents, trademarks and designs. For innovative entrepreneurs who wish to improve their intellectual property (IP) know-how, V.O. Patents & Trademarks organizes a basic course on IP on Thursday 26 September. Continue reading

IP World Summit 2019

Amsterdam, Paul van Vlissingenstraat, Leonardo Royal Hotel Amsterdam

IP World provides the opportunity to network with senior IP professionals from across the Globe, and from global corporates across the high tech, telecoms, software, pharmaceutical, retail, FMCG, online and oil & gas industries. Continue reading